封面
市場調查報告書
商品編碼
1247440

2023-2030 年電外科設備的全球市場

Global Electrosurgical Devices Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

電外科器械的全球市場規模預計到 2022 年為 59.842 億美元,到 2030 年將達到 95.661 億美元,預測期內(2023-2030 年)的複合年增長率為 6.3%。預計將在

電外科手術是外科手術中常用的一種技術,可快速消融軟組織並控制出血。 由於它們對電磁流的電阻,這些軟組織已經產生熱量。 電外科手術的終點取決於所使用的功率、波形和手術技術。 各種設備用於電外科手術,稱為電外科設備。

市場動態

推動全球電外科設備市場的主要因素是,由於慢性病、普通外科和神經外科等外科手術的增加,對先進設備的需求不斷增加;導致新產品發布的技術進步。

政府不斷加強改善擇期手術的舉措,以及技術進步導致新設備的開發,預計將推動市場增長。

隨著技術進步、人口老齡化、研發投資激增、神經退行性疾□□病和心髒病等慢性病患病率增加以及新興市場醫療基礎設施的改善,電外科設備市場正在擁抱最新技術。產品改進

電外科器械和附件廣泛用於外科手術。 這些儀器和設備的採用正在增加,導致政府的努力和資金增加。 這些資金將用於生產雙極和單極等電外科器械。 隨著需要這些器械的外科手術數量的增加,這些器械或設備的市場在世界範圍內不斷增加。 此外,預計主要參與者提供的技術先進的產品也將在市場增長中發揮重要作用。

與這些治療性電外科設備相關的各種新產品發布、研究和提高認識活動正在促進市場的增長。 例如,2022年8月,雅培宣布其新型Proclaim plus脊髓刺激系統獲得美國食品藥品監督管理局的批准。 它採用 FlexBurst360 療法,涵蓋六個肢體或核心區域的疼痛,並提供可根據個人治療需求進行調整的程序。

嚴格的產品審批規章制度和熟練勞動力短缺預計會阻礙市場增長。

關於批准外科手術中使用的電外科設備的嚴格規章制度是阻礙電外科設備市場增長的主要因素。 必須滿足各種要求和臨床試驗,從而增加了這些設備的總成本。

缺乏熟練的人員和專業人員是一個關鍵因素,因為電外科設備缺乏經驗,小錯誤可能導致死亡。 與這些電外科設備相關的高風險、巨大的治療成本以及需要重複治療的需求正在限制電外科設備市場的增長。

COVID-19 影響分析

疫情對全球金融預期、業務運營和危機應對策略產生了負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 COVID,電外科設備市場遭受了巨大損失。 主要製造商已經啟動了各種研究和臨床試驗。

世界各地正在開展各種舉措、產品發布、合作和合併,促進了市場的增長。 公眾對神經和心血管疾病以及外科治療等疾病的認識不斷提高,也將推動未來市場的發展。

內容

第 1 章研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 政府加大改善擇期手術的力度
      • 技術進步
      • 慢性病和日益老齡化的人口
    • 有一個限制因素:
      • 缺乏熟練的醫護人員
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析

第 6 章 COVID-19 分析

  • 市場上 COVID-19 的分析
    • 在 COVID-19 市場情景之前
    • 當前的 COVID-19 市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格和動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 結論

第 7 章按產品類型

  • 電外科器械和配件
    • 電外科儀器
      • 雙相
      • 單極
    • 電外科配件
  • 電外科發電機
  • 電動手術刀裝置
  • 氬煙管理系統

第八章應用

  • 普通外科
  • 婦科手術
  • 泌尿外科
  • 骨科
  • 心血管外科
  • 整容手術
  • 神經外科
  • 其他

第 9 章最終用戶

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 知名大公司名單

第12章公司簡介

  • 史賽克公司
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Boston Scientific Corporation
  • Symmetry Surgical Inc.
  • CONMED Corporation
  • Medtronic
  • Ethicon Johnson and Johnson
  • B. Braun SE
  • Smith+Nephew
  • Olympus Corporation
  • Abbott

第13章 DataM

簡介目錄
Product Code: MD1358

Market Overview

The global electrosurgical devices market size was valued at US$ 5,908.42 million in 2022 and is estimated to reach US$ 9,566.10 million by 2030, growing at a CAGR of 6.3% during the forecast period (2023-2030).

Electrosurgery is a technique generally used in surgery to rapidly dissect soft tissue and to control bleeding in surgery. These soft tissues electrical resistance to an electromagnetic current preoduces heat. The electrosurgery endpoints vary based on the power used, waveform and surgical technique. Various devices are used for electrosurgery known as electrosurgery devices.

Market Dynamics

The major factors driving the global electrosurgical devices market are the rising demand for advanced devices owing to increasing incidences of chronic disorders and surgical procedures such as general surgery or neurological surgery, surging awareness initiatives, advancements in technologies leading to novel product launches.

The increasing government initiatives to improve elective surgery and rising technological advancements leading to the development of new equipment are expected to drive the market's growth.

The electrosurgical devices market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of chronic disorders such as neurological degeneration as well as cardiologic disorders and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The electrosurgical devices and accessories are being used widely for surgeries. The adoption of these equipment or devices is increasing, leading to rising government initiatives and funds. These funds will help produce electrosurgical devices such as bipolar or monopolar devices. The market for these equipment or devices is increasing worldwide due to the enhanced number of these surgical procedures requiring these devices. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these electrosurgical devices for treatment contribute to the market's growth. For instance, in Aug 2022, Abbott announced the approval received for its novel Proclaim plus spinal cord stimulation system by the U.S. Food and Drug Administration. This features FlexBurst360 therapy that provides pain coverage over six limbs or trunk areas and offers programming that adjusts according to individual therapeutic needs.

Strict rules and regulations for the product approval and lack of skilled personnel are expected to hamper the market's growth.

Strict rules and regulations for the approval of electrosurgical devices utilized for surgical procedures is the major factor hindering the growth of the electrosurgical devices market. Various requirements, clinical trials must be fulfilled, leading to an increase in the overall cost of these equipment.

Lack of skilled personnel or expert is the important factor as there is less number of people with experience in using the electrosurgical devices and small mistake can lead to death. High risk related to these electrosurgical devices and huge expenses of the treatment and requirement of repeated sessions for treatments is restraining the electrosurgical devices market growth.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The electrosurgical devices market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials.

Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. The increasing awareness among the population regarding disorders such as neurological or cardiovascular and their treatment via surgical procedures will also drive the market in upcoming time.

Segment Analysis

The electrosurgical instruments and accessories segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The electrosurgical instruments and accessories segment is the highest market holder in the global electrosurgical devices market. The global electrosurgical devices market is segmented based on product type as electrosurgical instruments and accessories, electrosurgical generators, electrocautery devices, argon and smoke management systems. The optical coherence tomography segment is the largest market shareholder due to the increasing number of surgical procedures globally, increasing technological advancements and novel product launches.

Electrosurgical instruments and accessories is the most commonly used electrosurgical devices. The electrosurgical instruments includes bipolar and monopolar instruments and accessories. An electrosurgical unit (ESU) includes a handpiece and a generator with one or more electrodes. Using a switch on the foot switch or a handpiece, this device is controlled. Electrosurgical handpieces or accessories include return electrodes, specialty electrodes, suction coagulators and pencils.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market's growth. For instance, in September 2022, in Jun 2021, Medtronic, a medical technology company, announced that the SenSight directional lead system, the first U.S. implant utilized for the therapy of deep brain stimulation, got approved by the U.S. Food and Drug Administration. It is the first DBS directional lead combining the sensing power with the directionality for treating symptoms related to Parkinson's disease, refractory epilepsy and dystonia.

Geographical Analysis

North America holds the largest market share in the global electrosurgical devices market.

North America dominates the global electrosurgical devices market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of electrosurgical devices in several applications like neurosurgery, gynaecology surgery or general surgery, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the electrosurgical devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in March 8, 2021, Solta Medical, a business of Bausch Health Companies Inc., a medical aesthetics provider announced its next generation laser, Clear + Brilliant Touch laser in the U.S. launch. The Clear + Brilliant Touch laser provides a comprehensive and customized treatment protocol by offering patients of all skin types and ages the benefits of two wavelengths.

Competitive Landscape

The electrosurgical devices market is moderately competitive with local and global companies' presence. Stryker Corporation, Boston Scientific Corporation, Symmetry Surgical Inc., CONMED Corporation, Medtronic, Ethicon (Johnson and Johnson), B. Braun SE, Smith+Nephew, Olympus Corporation, Abbott and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in February 3, 2022, Sinclair, an aesthetics company and a subsidiary of Huadong Medicine Company Limited announced about acquiring Viora Group which boost its portfolio of energy-based devices (EBD) and provide a commercial base in the U.S. Viora's non-invasive advanced products are the highly advanced devices incorporating IPL, laser and proprietary RF technologies.

Boston Scientific Corporation Inc.

Overview: Boston is a multinational biomedical engineering company. It manufactures medical devices that include interventional cardiology, neurovascular intervention, cardiac surgery, oncology and vascular surgery. It also offers a minimally invasive implantable cardiovascular defibrillator. It was founded in 1979 and is headquartered in Massachusetts, U.S.

Product Portfolio: S-ICD System: this S-ICD system is the first subcutaneous implantable defibrillator that protects from cardiac arrest without touching the heart or vasculature. This system uses a pulse generator that can deliver life-saving therapy. It uses a subcutaneous electrode and monitors the heart rhythm.

Key Development: In Jan 2021, Boston Scientific Corp. announced its agreement to acquire Preventice Solutions Inc., a private company that provides products of mobile cardiac health solutions and services.

The global electrosurgical devices market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing government initiatives to improve elective surgery
      • 4.1.1.2. Increasing technological advancements
      • 4.1.1.3. Rise in chronic diseases and geriatric population
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled healthcare personnel
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Electrosurgical Instruments and Accessories*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
    • 7.2.3. Electrosurgery Instruments
      • 7.2.3.1. Bipolar
      • 7.2.3.2. Monopolar
    • 7.2.4. Electro surgery Accessories
  • 7.3. Electrosurgical Generators
  • 7.4. Electrocautery Devices
  • 7.5. Argon and Smoke Management Systems

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. General Surgery *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Gynecology Surgery
  • 8.4. Urologic Surgery
  • 8.5. Orthopedic Surgery
  • 8.6. Cardiovascular Surgery
  • 8.7. Cosmetic Surgery
  • 8.8. Neurosurgery
  • 8.9. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialized Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Stryker Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Boston Scientific Corporation
  • 12.3. Symmetry Surgical Inc.
  • 12.4. CONMED Corporation
  • 12.5. Medtronic
  • 12.6. Ethicon Johnson and Johnson
  • 12.7. B. Braun SE
  • 12.8. Smith+Nephew
  • 12.9. Olympus Corporation
  • 12.10. Abbott

LIST NOT EXHAUSTIVE

13. Global Electrosurgical Devices Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Medications
  • 13.3. Contact Us